By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

AbbVie

AbbVie unusual options activity for august 26 Benzinga19:18Pharma Biotech

AbbVie a top ranked safe Dividend stock with 3.2% Yield (ABBV) Nasdaq12:51Pharma

Pharma stocks analysis: Pfizer, Bristol-Myers Squibb, AbbVie Invezz10:02Pfizer Bristol Myers Squibb Pharma

3 Things You Need to Know if You Buy AbbVie Stock Today The Motley Fool17:16Pharma

AbbVie stock up almost 20% in 3 months: Buy, sell or hold? Zacks15:00Inflammatory Bowel Disease Stock Markets (World) Stock Market (US)

Prediction: Eli Lilly's latest move will threaten AbbVie stock The Motley Fool11:42Eli Lilly Pharma Tirzepatide

The future of bispecific antibodies in aggressive b-cell lymphomas Pharmacy Times21:39Genentech Pharma Biotech

15th World ADC San Diego 2024 pharmaphorum14:42Pfizer Tidal Power Merck & Co

AbbVie: CDA issues positive reimbursement recommendation for vraylar in treatment of schizophrenia RTT News13:27Canadian Politics Pharma Canada

Venetoclax by AbbVie for secondary acute myeloid leukemia: Likelihood of Approval Pharmaceutical Technology10:07Cancer Treatment Leukaemia Pharma

Latest News

Yesterday

AbbVie's Ubrelvy to be top migraine seller in 2033 as total market to hit $16B-plus across… FiercePharma12:26 10-Sept-24

In the last 7 days

The Future of Bispecific Antibodies in Aggressive B-Cell Lymphomas Pharmacy Times21:39 9-Sept-24

3 Things You Need to Know if You Buy AbbVie Stock Today The Motley Fool17:16 9-Sept-24

AbbVie Showcases Advancement of Solid Tumor Pipeline at ESMO 2024, with New Data in Tumor Types with High Unmet Needs AbbVie (Press Release)14:00 9-Sept-24

AbbVie a Top Ranked SAFE Dividend Stock With 3.2% Yield (ABBV) Nasdaq12:51 9-Sept-24

Venetoclax by AbbVie for Aplastic Anemia: Likelihood of Approval Pharmaceutical Technology10:07 9-Sept-24

Venetoclax by AbbVie for Secondary Acute Myeloid Leukemia: Likelihood of Approval Pharmaceutical Technology10:07 9-Sept-24

Risk adjusted net present value: What is the current valuation of AbbVie’s Navitoclax… Pharmaceutical Technology18:53 8-Sept-24

Risk adjusted net present value: What is the current valuation of AbbVie’s Tavapadon? Pharmaceutical Technology18:02 8-Sept-24

AbbVie Declares Quarterly Dividend PR Newswire (Press Release)15:15 6-Sept-24

Pharma stocks analysis: Pfizer, Bristol-Myers Squibb, AbbVie Invezz10:02 6-Sept-24

AbbVie maintains grip on TV drug ad spending list as pharma digs deep in August FiercePharma15:32 5-Sept-24

Allergan Aesthetics and University Lab Partners Announce NovoThelium as the Winner of the Golden Ticket Pitch… Newswise (Press Release)15:52 4-Sept-24

Multiple Myeloma Market Report and Company Analysis, 2024-2032 Featuring Novartis, AbbVie., Sanofi, Johnson & Johnson,… GlobeNewswire (Press Release)15:09 4-Sept-24

AbbVie Stock Up Almost 20% in 3 Months: Buy, Sell or Hold? Zacks15:00 4-Sept-24

The AbbVie Foundation and MATTER Launch the AbbVie Foundation Health Equity Accelerator Business Wire (Press Release)14:03 4-Sept-24

AbbVie: CDA Issues Positive Reimbursement Recommendation For Vraylar In Treatment Of Schizophrenia RTT News13:27 4-Sept-24

In the last month

Is AbbVie Stock Outperforming the Nasdaq? Barchart14:41 3-Sept-24

AbbVie's Ubrelvy wards off migraines when used in reaction to early warning signs: study FiercePharma17:09 29-Aug-24

AbbVie: Promising Developments On IBD Treatments Seeking Alpha15:24 29-Aug-24

AbbVie Already Has The Next Humira Seeking Alpha15:00 29-Aug-24

Aldeyra Therapeutics Has Data To Trigger AbbVie Partnership Seeking Alpha22:41 28-Aug-24

AbbVie: Stunning Turnaround, But No Longer A Bargain (Rating Downgrade) Seeking Alpha22:41 28-Aug-24

AbbVie: I'm Up 149% And Holding This Dividend Aristocrat Now Seeking Alpha22:41 28-Aug-24

Prediction: Eli Lilly's Latest Move Will Threaten AbbVie Stock The Motley Fool11:42 28-Aug-24

Why AbbVie Remains One Of My Favorite Dividend Growers Seeking Alpha23:49 27-Aug-24

AbbVie Awards Scholarships to 45 U.S. Students Living With Chronic Immune-Mediated Diseases AbbVie (Press Release)13:16 27-Aug-24

Cigna's Express Scripts to cross out AbbVie's Humira from some formularies in 2025, opting to… FiercePharma22:53 26-Aug-24

AbbVie Unusual Options Activity For August 26 Benzinga19:18 26-Aug-24

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year Mint17:41 26-Aug-24

Another major PBM will cut AbbVie's Humira from its largest commercial formularies ENDPOINTS16:38 26-Aug-24

15th World ADC San Diego 2024 pharmaphorum14:42 23-Aug-24

Autoimmune Disorder Drug Delivery Devices Market Exceed Growth rate (CAGR) of 16.89% Through… Industry Today12:39 21-Aug-24

AbbVie (ABBV) Gets Nod in EU for Lymphoma Drug's Expanded Use Zacks15:09 20-Aug-24

AbbVie launches new Skyrizi commercial after topping TV drug ad spenders’ ranking in July FiercePharma14:53 20-Aug-24

EC approves AbbVie’s TEPKINLY for follicular lymphoma Pharmaceutical Technology10:16 20-Aug-24

The Search For A Chemotherapy-Free Treatment For Patients With Blood Cancer Drugs Discovery Online05:07 19-Aug-24

Decoding AbbVie's Options Activity: What's the Big Picture? Benzinga18:41 14-Aug-24

The Zacks Analyst Blog Highlights Alphabet, AbbVie, Qualcomm and Flanigan's Zacks14:40 14-Aug-24

Analyst revises AbbieVie stock price target on drug sale estimates Bellingham Herald00:17 14-Aug-24

Prediction: Abbvie's Dividend Payouts Will Increase in 2025 24/7 Wall St.15:25 13-Aug-24

Life Sciences Community Advances Toward Next Phase of Innovation at Veeva R&D and Quality Summit PR Newswire (Press Release)12:04 13-Aug-24

AbbVie’s Skyrizi, Rinvoq retake the top TV drug ad spenders’ crown as top climber Rexulti… FiercePharma15:26 12-Aug-24

Africa HIV Drugs Market Poised for Robust Growth, Expected to Grow at a 8.20% CAGR By 2030 |… Industry Today13:01 12-Aug-24

view more headlines

10 Sept 12:26

AbbVie News

NewsNow aims to be the world's most accurate and comprehensive aggregator of AbbVie news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Publication filters

Notifications

Unsubscribe from Breaking News

Sorry, no headlines or news topics were found. Please try different keywords.